These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2907629)

  • 41. [Psychometric studies of performance deficits in acute schizophrenic patients with special reference to gender].
    Classen W; Laux G
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(1):31-40. PubMed ID: 1709296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flupenthixol decanoate and injection site abscesses in an obese patient.
    Andrade C
    Aust N Z J Psychiatry; 2002 Aug; 36(4):561-2. PubMed ID: 12169162
    [No Abstract]   [Full Text] [Related]  

  • 43. Transcranial direct current stimulation (tDCS) improved psychomotor slowness and decreased catatonia in a patient with schizophrenia: Case report.
    Chen CW; Lin SH; Huang LC; Yang YK
    Kaohsiung J Med Sci; 2018 Jun; 34(6):360-362. PubMed ID: 29747782
    [No Abstract]   [Full Text] [Related]  

  • 44. Cognitive impairment and clozapine.
    Carter J; Thrasher S; Thornicroft G
    Br J Psychiatry; 1994 Jan; 164(1):132-3. PubMed ID: 8137103
    [No Abstract]   [Full Text] [Related]  

  • 45. Dystonia and neuroleptic medication.
    Thorburn R
    Br J Psychiatry; 1995 Jul; 167(1):114. PubMed ID: 7551595
    [No Abstract]   [Full Text] [Related]  

  • 46. Haloperidol and cognitive shifting.
    Berger HJ; van Hoof JJ; van Spaendonck KP; Horstink MW; van den Bercken JH; Jaspers R; Cools AR
    Neuropsychologia; 1989; 27(5):629-39. PubMed ID: 2544823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intolerance to neuroleptics and susceptibility for malignant hyperthermia in a patient with proximal myotonic myopathy (PROMM) and schizophrenia.
    Schneider C; Pedrosa Gil F; Schneider M; Anetseder M; Kress W; Müller CR
    Neuromuscul Disord; 2002 Jan; 12(1):31-5. PubMed ID: 11731282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Flupentixol-induced acute hepatitis].
    Demuth N; Hastier P; Zermati L; Saint-Paul MC; Chichmanian RM; Delmont JP
    Gastroenterol Clin Biol; 1999 Jan; 23(1):152-3. PubMed ID: 10219622
    [No Abstract]   [Full Text] [Related]  

  • 49. Morphometry in schizophrenia revisited: height and its relationship to pre-morbid function.
    Kawai M; Takei N; Mori N
    Psychol Med; 1999 May; 29(3):753-4. PubMed ID: 10405097
    [No Abstract]   [Full Text] [Related]  

  • 50. Secondary parkinsonism with Mumps infection.
    Abbas MM; Basu P; Reginald V; Kumar RH; Muthane UB
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1288-9. PubMed ID: 26324210
    [No Abstract]   [Full Text] [Related]  

  • 51. Paroxysmal Perceptual Alterations in Response to Flupentixol.
    Phillips J; Barrera A
    J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):537-539. PubMed ID: 37930209
    [No Abstract]   [Full Text] [Related]  

  • 52. Thought disorders in schizophrenia before and after pharmacological treatment.
    Namyslowska I
    Compr Psychiatry; 1975; 16(1):37-42. PubMed ID: 1109833
    [No Abstract]   [Full Text] [Related]  

  • 53. Proportional impairment ratios: comment on McDonald et al., 2008.
    Hindmarch I
    Hum Psychopharmacol; 2009 Apr; 24(3):249-50. PubMed ID: 19330808
    [No Abstract]   [Full Text] [Related]  

  • 54. Case report: psychomotor status-like episodes under haloperidol treatment.
    Kaminer Y; Munitz H
    Br J Psychiatry; 1984 Jul; 145():87-8. PubMed ID: 6743950
    [No Abstract]   [Full Text] [Related]  

  • 55. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.
    Mahapatra J; Quraishi SN; David A; Sampson S; Adams CE
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001470. PubMed ID: 24915451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
    Larrauri JA; Levin ED
    Psychopharmacology (Berl); 2010 Dec; 212(4):551-8. PubMed ID: 20811878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine.
    Roegge CS; Perraut C; Hao X; Levin ED
    Pharmacol Biochem Behav; 2007 Apr; 86(4):686-92. PubMed ID: 17382376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm.
    Gemperle AY; McAllister KH; Olpe HR
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):354-64. PubMed ID: 12827343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia.
    Kores Plesnicar B; Zalar B; Tomori M; Krajnc I
    Wien Klin Wochenschr; 2003 Jan; 115(1-2):58-62. PubMed ID: 12658913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.